| When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients S Koga, N Aoki, RJ Uitti, JA Van Gerpen, WP Cheshire, KA Josephs, ... Neurology 85 (5), 404-412, 2015 | 380 | 2015 |
| Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies M Ono, N Sahara, K Kumata, B Ji, R Ni, S Koga, DW Dickson, ... Brain 140 (3), 764-780, 2017 | 239 | 2017 |
| Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy S Nasu, S Misawa, Y Sekiguchi, K Shibuya, K Kanai, Y Fujimaki, ... Journal of Neurology, Neurosurgery & Psychiatry 83 (5), 476-479, 2012 | 235 | 2012 |
| Neuropathology and molecular diagnosis of Synucleinopathies S Koga, H Sekiya, N Kondru, OA Ross, DW Dickson Molecular neurodegeneration 16 (1), 83, 2021 | 230 | 2021 |
| TDP-43 pathology in Alzheimer’s disease A Meneses, S Koga, J O’Leary, DW Dickson, G Bu, N Zhao Molecular neurodegeneration 16, 1-15, 2021 | 175 | 2021 |
| Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia M Prudencio, J Humphrey, S Pickles, AL Brown, SE Hill, JM Kachergus, ... The Journal of clinical investigation 130 (11), 2020 | 172 | 2020 |
| 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration E Saijo, MA Metrick, S Koga, P Parchi, I Litvan, S Spina, A Boxer, ... Acta neuropathologica 139, 63-77, 2020 | 137 | 2020 |
| APOE ε2 is associated with increased tau pathology in primary tauopathy N Zhao, CC Liu, AJ Van Ingelgom, C Linares, A Kurti, JA Knight, ... Nature communications 9 (1), 4388, 2018 | 137 | 2018 |
| Motor axonal excitability properties are strong predictors for survival in amyotrophic lateral sclerosis K Kanai, K Shibuya, Y Sato, S Misawa, S Nasu, Y Sekiguchi, S Mitsuma, ... Journal of Neurology, Neurosurgery & Psychiatry 83 (7), 734-738, 2012 | 133 | 2012 |
| Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy S Koga, DW Dickson Journal of Neurology, Neurosurgery & Psychiatry 89 (2), 175-184, 2018 | 129 | 2018 |
| Profile of cognitive impairment and underlying pathology in multiple system atrophy S Koga, A Parks, RJ Uitti, JA van Gerpen, WP Cheshire, ZK Wszolek, ... Movement Disorders 32 (3), 405-413, 2017 | 116 | 2017 |
| Pulmonary cysts of Birt-Hogg-Dubé syndrome: a clinicopathologic and immunohistochemical study of 9 families M Furuya, R Tanaka, S Koga, Y Yatabe, H Gotoda, S Takagi, YH Hsu, ... The American journal of surgical pathology 36 (4), 589-600, 2012 | 110 | 2012 |
| Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study E Jabbari, S Koga, RR Valentino, RH Reynolds, R Ferrari, MMX Tan, ... The Lancet Neurology 20 (2), 107-116, 2021 | 105 | 2021 |
| Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with α-synuclein N Aoki, PJ Boyer, C Lund, WL Lin, S Koga, OA Ross, M Weiner, A Lipton, ... Acta neuropathologica 130, 93-105, 2015 | 99 | 2015 |
| Sex and age interact to determine clinicopathologic differences in Alzheimer’s disease AM Liesinger, NR Graff-Radford, R Duara, RE Carter, ... Acta neuropathologica 136, 873-885, 2018 | 96 | 2018 |
| PET-detectable tau pathology correlates with long-term neuropsychiatric outcomes in patients with traumatic brain injury K Takahata, Y Kimura, N Sahara, S Koga, H Shimada, M Ichise, F Saito, ... Brain 142 (10), 3265-3279, 2019 | 77 | 2019 |
| Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP‐C S Koga, KA Josephs, K Ogaki, C Labbé, RJ Uitti, N Graff‐Radford, ... Movement Disorders 31 (5), 653-662, 2016 | 76 | 2016 |
| Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α‐synuclein pathology S Koga, M Ono, N Sahara, M Higuchi, DW Dickson Movement Disorders 32 (6), 884-892, 2017 | 73 | 2017 |
| Chronic traumatic encephalopathy pathology in multiple system atrophy S Koga, DW Dickson, KF Bieniek Journal of Neuropathology & Experimental Neurology 75 (10), 963-970, 2016 | 72 | 2016 |
| Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders K Ogaki, S Koga, MG Heckman, FC Fiesel, M Ando, C Labbé, ... Neurology 85 (23), 2016-2025, 2015 | 70 | 2015 |
Dennis W. DicksonMayo ClinicПідтверджена електронна адреса в mayo.edu
